Research background
IGF-1 LR3 is a 83-residue recombinant analog of insulin-like growth factor 1, extended by a 13-residue N-terminal sequence and substituted at position 3 (Arg for Glu). Both modifications sharply reduce binding to IGF binding proteins.


